Yamada Y, Kobayashi T, Condo A, et al. Prevalence of frailty and prefrailty in people with human immunodeficiency virus aged 50 or older: a systematic review and meta-analysis. Open Forum Infect Dis. 2022;9:ofac129. https://doi.org/10.1093/ofid/ofac129.

Article  PubMed  PubMed Central  Google Scholar 

Piggott DA, Erlandson KM, Yarasheski KE. Frailty in HIV: epidemiology, biology, measurement, interventions, and research needs. Curr HIV/AIDS Rep. 2016;13:340–8. https://doi.org/10.1007/s11904-016-0334-8.

Article  PubMed  PubMed Central  Google Scholar 

Peklar J, O’Halloran AM, Maidment ID, et al. Sedative load and frailty among community-dwelling population aged ≥65 years. J Am Med Dir Assoc. 2015;16(4):282–9. https://doi.org/10.1016/j.jamda.2014.10.010.

Article  PubMed  Google Scholar 

Wu C-S, Tseng H-Y, Lee C-Y, et al. Interactions of insomnia and sedative-hypnotic drug use associated with frailty over time among older adults. Am J Geriatr Psychiatry. 2023;31(6):438–48. https://doi.org/10.1016/j.jagp.2023.01.028.

Article  PubMed  Google Scholar 

Bergen AW, Cil G, Sargent LJ, et al. Frailty risks of prescription analgesics and sedatives across frailty models: the health and retirement study. Drugs Aging. 2022;39(5):377–87. https://doi.org/10.1007/s40266-022-00941-2.

Article  CAS  PubMed  Google Scholar 

Reallon E, Chavent B, Gervais F, et al. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study. Int J Clin Pharm. 2020;42:508–14. https://doi.org/10.1007/s11096-020-01007-2.

Article  CAS  PubMed  Google Scholar 

Ibrahim GM, Rutka JT, Snead OC. Network analysis reveals patterns of antiepileptic drug use in children with medically intractable epilepsy. Epilepsy Behav. 2013;28:22–5. https://doi.org/10.1016/j.yebeh.2013.03.030.

Article  PubMed  Google Scholar 

Cavallo P, Pagano S, Boccia G, et al. Network analysis of drug prescriptions. Pharmacoepidemiol Drug Saf. 2013;22(2):130–7. https://doi.org/10.1002/pds.3384.

Article  PubMed  Google Scholar 

Askar M, Cañadas RN, Svendsen K. An introduction to network analysis for studies of medication use. Res Social Adm Pharm. 2021;17(12):2054–61. https://doi.org/10.1016/j.sapharm.2021.06.021.

Article  PubMed  Google Scholar 

Bazzoni G, Marengoni A, Tettamanti M, et al. The Drug prescription network: a system-level view of drug co-prescription in community-dwelling elderly people. Rejuvenation Res. 2015;18(2):153–61. https://doi.org/10.1089/rej.2014.1628.

Article  CAS  PubMed  Google Scholar 

Dara ON, Ibrahim AA, Mohammed TA. Advancing medical imaging: detecting polypharmacy and adverse drug effects with Graph Convolutional Networks (GCN). BMC Med Imaging. 2024;24:174. https://doi.org/10.1186/s12880-024-01349-7.

Article  PubMed  PubMed Central  Google Scholar 

Rasmussen LD, Obel D, Kronborg G, et al. Utilization of psychotropic drugs prescribed to persons with and without HIV infection: a Danish nationwide population-based cohort study. HIV Med. 2014;15(8):458–69. https://doi.org/10.1111/hiv.12135.

Article  CAS  PubMed  Google Scholar 

Ayuso JL. Use of psychotropic drugs in patients with HIV infection. Drugs. 1994;47:599–610. https://doi.org/10.2165/00003495-199447040-00004.

Article  CAS  PubMed  Google Scholar 

Ailabouni N, Mangin D, Nishtala P. DEFEAT-polypharmacy: Deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm. 2019;41:167–78. https://doi.org/10.1007/s11096-019-00784-9.

Article  PubMed  Google Scholar 

Neville HL, Shaw J, VanIderstine C, et al. Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital patients. Int J Clin Pharm. 2023;45:1062–73. https://doi.org/10.1007/s11096-023-01632-7.

Article  PubMed  Google Scholar 

Mayo NE, Brouillette M-J, Fellows LK. Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials. BMC Neurol. 2016;16:8. https://doi.org/10.1186/s12883-016-0527-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mayo NE, Brouillette M-J, Scott SC, et al. Relationships between cognition, function, and quality of life among HIV+ Canadian men. Qual Life Res. 2020;29:37–55. https://doi.org/10.1007/s11136-019-02291-w.

Article  PubMed  Google Scholar 

Linjakumpu T, Hartikainen S, Klaukka T, et al. A model to classify the sedative load of drugs. Int J Geriatr Psychiatry. 2003;18(6):542–4. https://doi.org/10.1002/gps.846.

Article  CAS  PubMed  Google Scholar 

Linjakumpu TA, Hartikainen SA, Klaukka TJ, et al. Sedative drug use in the home-dwelling elderly. Ann Pharmacother. 2004;38(12):2017–22. https://doi.org/10.1345/aph.1E067.

Article  PubMed  Google Scholar 

Pathai S, Bajillan H, Landay AL, et al. Is HIV a model of accelerated or accentuated aging? J Gerontol Ser A. 2014;69:833–42. https://doi.org/10.1093/gerona/glt168.

Article  Google Scholar 

Vinuesa-Hernando JM, Gimeno-Gracia M, Malo S, et al. Potentially inappropriate prescriptions and therapeutic complexity in older HIV patients with comorbidities. Int J Clin Pharm. 2021;43:1245–50. https://doi.org/10.1007/s11096-021-01242-1.

Article  PubMed  Google Scholar 

Michael HU, Brouillette M-J, Tamblyn R, et al. Cognitive impact of anticholinergic and sedative burden in people with HIV. AIDS. 2024;38(13):1819–28. https://doi.org/10.1097/QAD.0000000000003966.

Article  CAS  PubMed  Google Scholar 

Michael HU, Brouillette M-J, Tamblyn R, et al. The association between anticholinergic/sedative burden and physical frailty in people aging with HIV. AIDS. 2024;38(4):509–19. https://doi.org/10.1097/QAD.0000000000003806.

Article  CAS  PubMed  Google Scholar 

Inceer M, Brouillette M-J, Fellows LK, et al. Factors partitioning physical frailty in people aging with HIV: a classification and regression tree approach. HIV Med. 2022;23(7):738–49. https://doi.org/10.1111/hiv.13236.

Article  CAS  PubMed  Google Scholar 

Bedru HD, Yu S, Xiao X, et al. Big networks: a survey. Comput Sci Rev. 2020;37: 100247. https://doi.org/10.1016/j.cosrev.2020.100247.

Article  Google Scholar 

Girvan M, Newman MEJ. Community structure in social and biological networks. Proc Natl Acad Sci. 2002;99(12):7821–6. https://doi.org/10.1073/pnas.122653799.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin C, Niemeyer P. On the impact of network size and average degree on the robustness of centrality measures. Netw Sci. 2021;9(S1):S61–82. https://doi.org/10.1017/nws.2020.37.

Article  Google Scholar 

Newman MEJ. Measures and metrics: an introduction to some standard measures and metrics for quantifying network structure, many of which were introduced first in the study of social networks, although they are now in wide use in many other areas, Networks: An Introduction, 1st edn (Oxford, 2010; online edn, Oxford Academic, 2010), https://doi.org/10.1093/acprof:oso/9780199206650.003.0007. Accessed 24 May 2025.

Hevey D. Network analysis: a brief overview and tutorial. Health Psychol Behav Med. 2018;6(1):301–28. https://doi.org/10.1080/21642850.2018.1521283.

Article  PubMed  PubMed Central  Google Scholar 

Martinez-De la Torre A, van Weenen E, Kraus M, et al. A Network analysis of drug combinations associated with acute generalized exanthematous pustulosis (AGEP). J Clin Med. 2021;10(19):4486. https://doi.org/10.3390/jcm10194486.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Norén GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res. 2013;22(1):57–69. https://doi.org/10.1177/0962280211403604.

Article